Stub Trade on Samsung C&T with BioLogics as a Sole Pair Partner
The lastĀ Samsung C&T (028260 KS) block deals ended last month on Sep 20. C&T is now free of circular shareholding links. That is, C&T...
617 Views
Celltrion: Understanding Inflectra's U.S. Challenges
Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...
753 Views
Samsung C&T Placement: Finally First Step Towards a Legit Holding Company
I would take this deal.Ā I believe the market will interpret this placement as the starting point of C&T-centered holding company conversion....
627 Views
BBSP ASIA Equity Asia Weekly Research - 19 Sep 2018
THE MAIN IDEA(Relative Value Approach in USD Terms)Long Term Allocation (Strategic view) Relative Value vs MXAP in USD termsā¦ NIKKEI/MXAP: Long...
440 Views
Hyundai Motor Group Restructuring Update - Revised Plan Summary
We had another interesting day yesterday. Samsung made a headline with its jaw-dropping investment size (a totalĀ ā©180tril). Samsung Biologics Co.,...
550 Views